The effect of oral lavender essential oil on menopausal symptoms, serum lipid profile, and cortisol concentration in postmenopausal wome
- Conditions
- Menopausal symptoms.Menopausal and other perimenopausal disorders
- Registration Number
- IRCT20131009014957N13
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 72
Willingness to participate in the study
Be literate enough to fill out a questionnaire or presence of a literate person in the family
Having a normal menopause
Women who were menopause less than 6 years ago
Having a minimum of 45 and a maximum of 60 years of age
Earning a minimum score of 15 and a maximum of 42 in the Green assessment
Use of tobacco and alcoholic beverages and herbal medicines
Existence of stressors such as the death of first-degree relatives in the last 6 months and job loss
Existence of malignant disease
Recent history of surgery and trauma
Lavender consumption during the 3 months before the study
Use of hormone therapy during the past 6 months
Having known physical and mental illnesses according to self-expression (depression, uncontrolled diabetes, cardiovascular diseases)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Green scale symptoms score in postmenopausal women. Timepoint: Before and after intervention. Method of measurement: Green questionnaire.;Serum cortisol levels. Timepoint: Before and after intervention. Method of measurement: Enzyme-linked immunosorbent assay (ELISA) method by ELISA kits.
- Secondary Outcome Measures
Name Time Method Reported possible side effects. Timepoint: After the intervention. Method of measurement: Checklist of possible side effects.;The level of satisfaction with the intervention received. Timepoint: After the intervention. Method of measurement: Satisfaction checklist received from the intervention.;Serum levels of lipid profile. Timepoint: Before and after intervention. Method of measurement: By spectrophotometric method with device with Alcyon 300 model and Pars test kit.